MOESM1 of Modeling and rescue of defective blood–brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients

Additional file 1: Table S1. Information on induced pluripotent stem cell (iPSC) lines used in study. Table S2. Primary antibodies used for immunocytochemistry. Table S3. Secondary antibodies used for immunocytochemistry. Table S4. Primers used for RT-PCR. Figure S1. Polymer characterization data. Figure S2. Representative immunocytochemistry images of iBMEC lines not shown in main manuscript. Figure S3. P-glycoprotein (P-gp) expression and function. Figure S4. TEER measurements for individual cell lines. Figure S5. Additional representative TEM images. Figure S6. Oil-Red-O staining and quantification of WT and ccALD-iPSCs. Figure S7. Timing and dosage effect of polymer treatment